Eva Löfvenberg

A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony‐stimulating factor: significant effects on quality of life

Eva Hellström‐Lindberg, Nina Gulbrandsen, Greger Lindberg et al. · British Journal of Haematology · 2003 · 454 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Treatment of Anemia in Myelodysplastic Syndromes With Granulocyte Colony-Stimulating Factor Plus Erythropoietin: Results From a Randomized Phase II Study and Long-Term Follow-Up of 71 Patients

Eva Hellström-Lindberg, Tomas Ahlgren, Yves Béguin et al. · Blood · 1998 · 306 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Management of polycythaemia vera, essential thrombocythaemia and myelofibrosis with hydroxyurea*

Eva Löfvenberg, Anders Wåhlin · European Journal Of Haematology · 1988 · 159 citations

Medicine, Hematology, Pharmacology +12

Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study

Harald Holte, Sirpa Leppä, Magnus Björkholm et al. · Annals of Oncology · 2012 · 117 citations · Full text

Medicine, Hematology, Oncology +11

Chlorambucil/prednisone vs. CHOP in symptomatic low-grade non-Hodgkin's lymphomas: A randomized trial from the Lymphoma Group of Central Sweden

Eva Kimby, Magnus Björkholm, G Gahrton et al. · Annals of Oncology · 1994 · 97 citations · Full text

Medicine, Oncology, Pharmacotherapy +11